
About Eulysis
Eulysis is a Healthcare company based in Cambridge (United States) founded in 2010. Diabetes management and lifestyle modification services are provided. Eulysis has raised $4.8 million across 3 funding rounds from investors including Google and 43North. Its focus areas include Biopharma Outsourcing, Logistics & Supply Chain and Packaging. Its legal entity is EULYSIS UK LIMITED. Its competitors include Legacy Pharma Solutions and Nutra-Med Packaging.
Company details
Eulysis was founded in 2010 and is located in Cambridge, United States. Operations center on diabetes care within the healthcare sector, where services including dietary guidance, exercise programs, and medical oversight are delivered. A specialized diet kitchen is maintained to advise on suitable food selections. Educational materials are distributed to support patient self-management and overall health control.
- Headquarters Cambridge, United States
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website eulysis.com
- Social LinkedIn X
- Legal Name Eulysis Uk Limited
- Total Equity Funding$4.8M (USD)
in 3 rounds
- Latest Funding Round$3.2M (USD), Series A
Jun 2015
- InvestorsGoogle
& 1 more
Funding Insights of Eulysis
Eulysis has successfully raised a total of $4.8M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $3.2 million completed in June 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $4.8M
- Total Rounds 3
- Last Round Series A β $3.2M
- First Round $500,000
(Oct 2014)
- Investors Count 2
All 3 funding rounds of Eulysis with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
2 investors in total: 2 institutional.
Investors in Eulysis
Eulysis has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Google and 43North.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Seed-stage investments are targeted by 43North in startups. | 43north.org | Buffalo, United States | ||
A technology company offering products and services, including search engine, cloud computing, advertising, email, productivity software, and more | 1998 | google.com | Mountain View, United States |
Investor details for Eulysis
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Eulysis
1 people are tracked at Eulysis (1 in leadership).
| Name | Role | Group |
|---|---|---|
Spyridon 'Ross' Tsakas | Founder and President | Leadership |
Complete people profiles for Eulysis
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Eulysis
3 dated milestones of Eulysis across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Eulysis is founded.
- Funding First funding round of $500K.
- Funding Latest funding round, Series A, of $3.2M.
Competitors of Eulysis
Eulysis has 2 listed competitors in our database. They include Legacy Pharma Solutions and Nutra-Med Packaging.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| legacypackaging.com | 2003 | Earth, United States | 331 | Contract pharmaceutical packaging company | ||
| nutra-med.com | 1999 | Hanover, United States | Provider of drugs packaging services |
Detailed competitors of Eulysis
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as Eulysis (Biopharma Outsourcing & Drug Delivery) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Suite solutions are provided for payers and healthcare providers. | 1998 | Princeton, New Jersey, United States | USD 220 M | USD 374.1 M | 5,666 | |
Wearable insulin infusion systems are developed for diabetes patients. | 2000 | Boston, Massachusetts, United States | USD 120.4 M | USD 2.71 B | 3,900 | |
Developer of small-molecule drugs | 1991 | Los Angeles, California, United States | USD 50 M | USD 348.97 M | 407 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Eulysis
Eulysis was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Eulysis is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Eulysis is a funded company, having raised a total of $4.8M across 3 funding rounds to date. The company's 1st funding round was a Grant of $500K, raised on Oct 2014.
Eulysis was founded in 2010 and is located in Cambridge, United States. Operations center on diabetes care within the healthcare sector, where services including dietary guidance, exercise programs, and medical oversight are delivered. A specialized diet kitchen is maintained to advise on suitable food selections. Educational materials are distributed to support patient self-management and overall health control.
Eulysis's top competitors include Legacy Pharma Solutions and Nutra-Med Packaging.
Eulysis operates through Eulysis Uk Limited.